Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval

April 4, 2016 • by Marc Airhart

The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).

White bacterial coloines on a plate of red culture medium

Colonies of the bacterium Bacillus anthracis, which causes anthrax, at 10x magnification. Photo credit: Todd Parker/CDC.


Share


Illustration shows how atom-thin materials enable control of individual photons of light

Texas Quantum Institute

Quantum Leap for STEM Graduate Training at UT

Against a backdrop of spinach leaves are old-time news clips with headlines "U.T. Scientists Find New Vitamins in Spinach: Why Popeye Has Big Msucles" and "New 'Life Staff' Found in Spinach" and "Three U.T. Scientists Discover New Vitamin"

UT News

4 Tons of Spinach, 3 Professors and 1 Life-Changing Discovery

A montage of six young people, many in outdoor settings is surrounded by graphics of lines and squares.

UT Biodiversity Center

Announcing the 2025 Stengl-Wyer Scholars, Fellows and Grant Awardees